Global Cord Blood (CO) Competitors $0.71 0.00 (0.00%) As of 08/1/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock CO vs. CORBF, MRAI, FHTX, EHAB, VSTM, RCKT, INBX, ABEO, AVIR, and ANNAShould you be buying Global Cord Blood stock or one of its competitors? The main competitors of Global Cord Blood include Global Cord Blood (CORBF), Marpai (MRAI), Foghorn Therapeutics (FHTX), Enhabit (EHAB), Verastem (VSTM), Rocket Pharmaceuticals (RCKT), Inhibrx Biosciences (INBX), Abeona Therapeutics (ABEO), Atea Pharmaceuticals (AVIR), and AleAnna (ANNA). Global Cord Blood vs. Its Competitors Global Cord Blood Marpai Foghorn Therapeutics Enhabit Verastem Rocket Pharmaceuticals Inhibrx Biosciences Abeona Therapeutics Atea Pharmaceuticals AleAnna Global Cord Blood (NYSE:CO) and Global Cord Blood (NYSE:CORBF) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation, dividends and media sentiment. Is CO or CORBF more profitable? Company Net Margins Return on Equity Return on Assets Global Cord BloodN/A N/A N/A Global Cord Blood N/A N/A N/A Which has more risk & volatility, CO or CORBF? Global Cord Blood has a beta of 0.16, suggesting that its stock price is 84% less volatile than the S&P 500. Comparatively, Global Cord Blood has a beta of -0.52, suggesting that its stock price is 152% less volatile than the S&P 500. Does the media prefer CO or CORBF? In the previous week, Global Cord Blood's average media sentiment score of 0.00 equaled Global Cord Blood'saverage media sentiment score. Company Overall Sentiment Global Cord Blood Neutral Global Cord Blood Neutral Which has stronger earnings & valuation, CO or CORBF? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGlobal Cord Blood$1.24B0.07$79.04M$0.641.11Global Cord Blood$196.12M0.44$79.04MN/AN/A SummaryGlobal Cord Blood beats Global Cord Blood on 2 of the 3 factors compared between the two stocks. Get Global Cord Blood News Delivered to You Automatically Sign up to receive the latest news and ratings for CO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CO vs. The Competition Export to ExcelMetricGlobal Cord Bloodhealth & allied services, not elsewhere classified IndustryMedical SectorNYSE ExchangeMarket Cap$86.30M$64.04M$5.52B$20.47BDividend YieldN/AN/A4.74%3.71%P/E Ratio1.110.5528.9629.02Price / Sales0.070.36440.5157.15Price / Cash4.192.8035.0722.46Price / Book0.110.118.254.43Net Income$79.04M$43.11M$3.25B$993.74M7 Day PerformanceN/A-3.31%-3.75%-3.40%1 Month PerformanceN/A-38.22%2.99%-2.70%1 Year Performance-52.67%7.18%25.34%10.16% Global Cord Blood Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)COGlobal Cord BloodN/A$0.71flatN/AN/A$86.30M$1.24B1.111,202CORBFGlobal Cord BloodN/A$0.71+29.1%N/AN/A$86.30M$196.12M0.001,200MRAIMarpaiN/A$1.31flatN/A+126.9%$21.66M$34.87M-0.50150Upcoming EarningsGap DownFHTXFoghorn Therapeutics2.4912 of 5 stars$6.50+5.0%$12.13+86.5%-18.5%$345.04M$22.60M-4.78120Upcoming EarningsGap DownEHABEnhabit2.3681 of 5 stars$6.79+0.6%$8.75+28.9%-32.5%$341.80M$1.03B-2.4510,700Upcoming EarningsVSTMVerastem2.4753 of 5 stars$6.02-2.0%$13.38+122.2%+142.2%$337.39M$10K-1.8850News CoverageUpcoming EarningsShort Interest ↑Gap DownRCKTRocket Pharmaceuticals4.8363 of 5 stars$3.11-1.0%$17.87+474.5%-85.7%$335.31MN/A-1.18240Trending NewsUpcoming EarningsINBXInhibrx Biosciences1.3527 of 5 stars$24.57+6.5%N/A+51.8%$334.11M$200K0.21166ABEOAbeona Therapeutics3.8496 of 5 stars$6.62+1.4%$19.25+190.8%+38.1%$334.05M$3.50M-5.2190News CoverageAVIRAtea Pharmaceuticals1.5399 of 5 stars$3.79-2.8%$6.00+58.3%+0.6%$333.76MN/A-2.3070News CoverageUpcoming EarningsANNAAleAnnaN/A$4.81-3.4%N/AN/A$331.62M$1.42M-240.50N/APositive News Related Companies and Tools Related Companies CORBF Competitors MRAI Competitors FHTX Competitors EHAB Competitors VSTM Competitors RCKT Competitors INBX Competitors ABEO Competitors AVIR Competitors ANNA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CO) was last updated on 8/3/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredIf you saw this, you'd be scared tooMarkets may look strong—but one veteran analyst warns we’re nearing a financial breaking point. After 40+ y...InvestorPlace | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global Cord Blood Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Global Cord Blood With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CO Stock Alerts